Looks like Arrayit is updating their website. Work in progress...

They anticipate...

At least that is 3,057,325,268 fewer shares in the marketplace.

Looks like they paid themselves back their own shares.

I found it. Still there.

Dividend tweet? I don't see it now.

Wow, a $10,039.20 fine for Dr. Taguchi

Two years certification, actually - 2022!

All good to next year.
https://investorshub.advfn.com/uimage/uploads/2020/6/8/xbowxA3B88E23-B2C0-4ADC-AB37-614A6A93E7D1.png

PCSO parent company... https://www.firstifg.com/

This what you’re looking for?

http://www.arrayit.com/EReply.html?#contactus

See What We Provide!
Our tests can be requested through your health care providor including doctor offices, clinics, hospitals, health maintenance and preferred provider organizations (HMOs and PPOs). Arrayit SARS-CoV-2 antibody testing services are covered by the top health insurance payors including Medicare, Medicaid and major private insurers to maximize customer convenience.

SARS-CoV-2 antibody Testing
Fingerstick Blood Test
Arrayit SARS-CoV-2 antibody tests use a few drops of patient blood from a fingerstick on a blood collection card. Fingerstick testing makes our healthcare services convenient and patient-friendly. Doctors are increasingly prescribing our tests for all Americans especially pediatric and special needs patients.

Top Standards
Clinical Laboratory
Certified by the California Department of Public Health and the Center for Medicare and Medicaid Services Clinical Laboratory Improvement Amendments (CLIA) and benchmarked by the College of American Pathologists (CAP). Compliance with the United States Food and Drug Administration (FDA) ensures that our clinical services conform to the highest standards.

CLIA Lab Compliance and FDA Approval
by the College of American Pathologists
As of this date, our CLIA laboratory had notified the FDA that it had validated, and is now offering, their COVID-19 test under the FDA’s guidelines, “Policy for Diagnostic Tests for Coronavirus Disease 2019.” Our laboratory is now offering this test while we await an official EUA status letter from the FDA. Our COVID-19 test measures IgG reactions to 12 epitomes (proteins) that are specific to COVID-19

Healthcare Testing
Innovative Solutions
In addition to Arrayit offering SARS-CoV-2 antibody testing, we have a rich healthcare testing services pipeline that includes innovative solutions for the oncology, neurologic and family health marketplaces. These services will allow us to leverage our advanced technology in new and important healthcare segments.

Next Generation Healthcare
Biomarkers
The human body expresses real-time protein markers in the bloodstream indicative of our health and wellness. Arrayit testing services measure the level of these bloodstream markers to afford physicians with next generation healthcare information.

Oncology
Advanced Cancer Detection
Microarray tests for ovarian cancer, colon cancer and other cancers measure the activation of the immune system in response to tumor cell development. Pre-symptomatic and early stage cancer detection improves patient prognosis and healthcare treatment options. Talk to your Doctor about other wellness testing.

Follow the link at the bottom of the page.

http://arrayit.com/
"Order Your Allergy and COVID-19 Test Kit Today!"

Detect chromosomal abnormalities
We are pleased to announce that CancerRop has validated our scanner InnoScan 710 for all their BAC CHIP arrays. Their arrays can also be used with the scanner InnoScan 910.

BAC CHIP are utilized for detecting chromosomal abnormalities in embryos for increasing success rate of in vitro fertilization (P-chip), checking health of fetus (M-chip) and diagnosing chromosomal abnormalities in children and adults who have health problems (G-Chip). BAC CHIP also can detect chromosomal abnormalities in cancer cells (C-chip) and check chromosomal abnormalities in stem cells (S-chip).
https://www.innopsys.com/en/lifesciences-company/lifesciences-news/highlights/754-innoscan-validation-for-cancerrop-bac-chip-arrays

CancerROP
Beyond New Horizon
We develop new technologies
Canslop Co., Ltd. is a comprehensive anti-cancer biomedical company that penetrates the entire cycle of chemotherapy from diagnosis to cure.
http://www.cancerrop.com/company/?url=company

White paper...

Executive Summary
The purpose of this white paper is to discuss the advantage in investing in Protective Capital Structures Cop. (PCSO) due to its Business Collateral Line of Credit (BCLOC) Security product. With the BCLOC Security, PCSO can process and fund billions of dollars in Securities in order to finance large projects (Real-estate and others) world wide. The BCLOC Security has produced and can produce 4% (in points) and an interest rate that is very competitive. PCSO has no debt because it does not take deposit, but its client must issue bonds or sell marketable securities, which is used to pay PCSO in cash over time. PCSO currently sits at a market value of over $22 billion , assets of $136 billion , with no debt. Additionally, the 2019 3rd quarter net revenue calculated to $7 billion with expenses of .001 %. The revenue is based on an accrual rate due to over 10 years of BCLOC dormancy. Consequently, the company’s dormancy period creates a lack of current operational cash liquidity. Previous PCSO management could not convert the BCLOC Security into cash due to lack of complete understanding of the product. Previous management inapporpriately associated the product with a commercial mortgage. This led PCSO trustee, Ed Johnson to relaunch PCSO in 2019 by hiring and educating new management on the BCLOC functions and to explain that it is not a commercial mortgage. The BCLOC Security is a combination of hybrid security and derivative structure of products, which is designed to withstand any type of open-market default. The BCLOC runs exclusively on Access Partner FinTech software (owned by Access Channel inc. a PCSO company). This paper will provide a detailed explanation of our innovative product and its long term benefits to clients.

https://pcso1.com/wp-content/uploads/2020/03/BCLOC-White-Paper-March-2020-2-1.pdf

I love my pig! Go pig, go!

Number of Board Members / Advisors, 8
Sylvatex Inc has 8 board members and advisors, including Rene Schena.
Rene Schena, Board Member
Susan Hwang, Advisor
Jo Anne Miller, Advisor
Christopher Weaver, Advisor
Bruce Rubin, Board Member
Shane Khoh, Board Member
Robert Ames, Advisor
Ronald Wright, Advisor
https://www.crunchbase.com/organization/sylvatex#section-current-team

SBIR Phase II: Development of Renewable Nanoparticle Platform for Green Energy Production and Storage Applications
Agency: National Science Foundation
Branch: N/A
Contract: 1927077
Agency Tracking Number: 1927077
Amount: $749,263.00
Phase: Phase II
Program: SBIR

Sylvatex, Inc.
927 Thompson Place, Sunnyvale, CA, 94085
https://www.sbir.gov/sbirsearch/detail/1644635

https://sylvatex.com/
https://www.nrel.gov/docs/fy18osti/70914.pdf

Global Tissue Analysis Products Market Insights Report 2020-2026 with Coronavirus (COVID-19) Effect Analysis : Sigma-Aldrich, LC Sciences, GE Healthcare, Partec, Carl Zeiss, Mindray
3 days ago

Tissue Analysis Products Market Report 2020-2026
An in-depth market research study titled Global "Tissue Analysis Products Market" highlights several significant facets related to the Tissue Analysis Products market encompassing competitive landscape, segmentation analysis, and industry environment. The report details key statistics on the market position of the Tissue Analysis Products manufacturers is a proven valuable trajectory of guidelines and direction for companies and individuals interested in consolidating their position in the market. Realistic concepts of the market are explained lucidly in this report. The COVID-19 outbreak is currently going the world over, this report covers the impact of the corona-virus on leading companies in the ### sector. This research report also gives a comprehensive study of Covid-19 impact analysis of the market by type, application and by regions like (Americas, APAC, and EMEA).

Major Market Players Covered In This Report: Sigma-Aldrich, LC Sciences, GE Healthcare, Partec, Carl Zeiss, Mindray, Analytical Biological Services, Sony Biotechnology, Stem Cell Technologies, TTP LabTech, EMD Millipore, Abnova, Apogee Flow Systems, Miltenyi Biotec, Arrayit

http://nwctrail.com/2020/05/09/global-tissue-analysis-products-market-insights-report-2020-2026-with-coronavirus-covid-19-effect-analysis-sigma-aldrich-lc-sciences-ge-healthcare-partec-carl-zeiss-mindray/

Global Complementary DNA Microarrays (cDNA) Market 2020- Impact of COVID-19, Future Growth Analysis and Challenges | Illumnia, Affymetrix, Agilent, Scienion AG, Applied Microarrays
May 8, 2020

The report involves insightful data on the main sectors of the Global Complementary DNA Microarrays (cDNA) Market. The report has segmented market, by its types and applications. Each segment has analyzed completely on the basis of its production, consumption as well as revenue. Further, it is classified on the basis of geographical areas which include: North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

The study on the Complementary DNA Microarrays (cDNA) market provides complete report on changing market trends for this market. It offers market size and share of each separate segment in the market. Many companies are involved in this market. Top players are completely profiled in this report.

Our best analysts have surveyed the market report with the reference of inventories and data given by the key players:
Illumnia
Affymetrix
Agilent
Scienion AG
Applied Microarrays
Arrayit
Sengenics
Biometrix Technology
Savyon Diagnostics
WaferGen

https://galusaustralis.com/2020/05/633686/global-complementary-dna-microarrays-cdna-market-2020-impact-of-covid-19-future-growth-analysis-and-challenges-illumnia-affymetrix-agilent-scienion-ag-applied-microarrays/

Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast 2020-2025, Latest Trends and Opportunities
Date: May 06, 2020

This report also researches and evaluates the impact of Covid-19 outbreak on the Commercializing Biomarkers in Therapeutic and Diagnostic Applications industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Commercializing Biomarkers in Therapeutic and Diagnostic Applications and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Commercializing Biomarkers in Therapeutic and Diagnostic Applications market competition by top Manufacturers:
Roche
Dako (Agilent Technologies)
Merck
BD
Abbott
Genesys Biolabs (20/20GeneSystems)
Affymetrix
Agendia
ALMAC
Arrayit
Biocartic
BG Medicine
KEGG EXPRESSION Database
Thermo Fisher
BGI

https://www.zzreport.com/commercializing-biomarkers-in-therapeutic-and-diagnostic-applications-market-2854/

Global DNA and Gene Chips Market With COVID-19 Impact Analysis, Outlook and Forecast to 2026 | Perkin Elmer Inc., Illumina Inc., Thermo Fisher Scientific Inc., Macrogen Inc.
14 hours ago

DNA and Gene Chips Market (By Major Eminent Players, Types, Applications, and Leading Regions) Segments Outlook, Business Assessment, Competition Scenario, Trends and Forecast by Upcoming Years. The study of the DNA and Gene Chips market report is done based on the noteworthy research methodology that provides the analytical inspection of the global market based on various segments the Industry is alienated into also the summary and Advance size of the marketplace owing to the various outlook possibilities. The report also gives information about the key players of the DNA and Gene Chips Industry by different features that include the DNA and Gene Chips overview of the companies, the portfolio of the product and also the revenue facts from Period of Forecast, As Well. It presents a 360-degree overview of the competitive landscape of the industries. SWOT Analysis has been used to understand the Strength, Weaknesses, Opportunities, and threats in front of the businesses. Thus, helping the companies to understand the threats and challenges in front of the businesses. DNA and Gene Chips market is showing steady growth and CAGR is expected to improve during the forecast period. This is the latest report covering the current impact of COVID-19 on the market.

This Report Covers Leading Companies Associated in Worldwide DNA and Gene Chips Market: Perkin Elmer Inc., Illumina Inc., Thermo Fisher Scientific Inc., Macrogen Inc., Agilent Technologies, Greiner Bio-One International GmbH, Asper Biotech, CapitalBio Corporation, Microarrays Inc., Oxford Gene Technology, Arrayit Corporation, bioMérieux SA.

http://nwctrail.com/2020/05/12/global-dna-and-gene-chips-market-with-covid-19-impact-analysis-outlook-and-forecast-to-2026-perkin-elmer-inc-illumina-inc-thermo-fisher-scientific-inc-macrogen-inc/

GLOBAL DNA MICROARRAY MARKET REGISTER A XX% CAGR IN TERMS OF REVENUE BY 2025: ILLUMNIA, AFFYMETRIX, AGILENT TECHNOLOGIES, ROCHE NIMBLEGEN, SENGENICS, ARRAYIT
MAY 12, 2020

Global DNA Microarray Market Register a xx% CAGR in Terms of Revenue By 2025: Illumnia, Affymetrix, Agilent Technologies, Roche NimbleGen, sengenics, Arrayit

A research report on the Global DNA Microarray Market offers a detailed analysis about the market share, size, trends, and growth prospects. In addition, the report contains market volume with an accurate estimation offered in the report. The data offered in this report is gathered based on the latest industry news, trends, as well as opportunities. Moreover, the report comprises a complete market analysis and provider landscape with the help of SWOT analysis of the major service providers. This research report provides an extensive evaluation of the DNA Microarray Market. The Global DNA Microarray Market report is designed through the detailed qualitative insights, verifiable projections, and historical data about the DNA Microarray Market size.

This study covers following key players:
Illumnia
Affymetrix
Agilent Technologies
Roche NimbleGen
sengenics
Arrayit
Applied Microarrays
Biometrix Technology
Savyon Diagnostics
Scienion AG
WaferGen

https://coleofduty.com/market-reports/2020/05/12/global-dna-microarray-market-register-a-xx-cagr-in-terms-of-revenue-by-2025-illumnia-affymetrix-agilent-technologies-roche-nimblegen-sengenics-arrayit/

ARRAY INSTRUMENTS MARKET ANALYZES THE IMPACT FOLLOWED BY RESTRAINTS AND OPPORTUNITIES AND PROJECTED DEVELOPMENTS (2020-2027)
MAY 12, 2020

Array Instruments Market analyzes the impact followed by restraints and opportunities and projected developments (2020-2027)

Market Expertz has recently published a study titled ‘Global Array Instruments Market Research Report.’ In this report, analysts have provided a detailed evaluation of the global Array Instruments market. It includes a comprehensive study of the Array Instruments Market alongside all the important factors that are likely to have an impact on the commercialization matrix of the market.

This is the only report that is inclusive of the current effect of the coronavirus on the market and its forecasted trend. The coronavirus attack on the global economy has affected all industries, and its impacts are presented in detail in the report.

Leading Array Instruments manufacturers/companies operating at both regional and global levels:
Affymetrix
Agilent Technologies
Illumina
Arrayit
Asterand
Laboratory Corporation of America Holdings
OriGene Technologies
Orla Protein Technologies
Oxford Gene Technology
Partek
Pepscan
Perkin Elmer
Phalanx Biotech Group
ProteoGenix
Qiagen
RayBiotech
Retrogenix
Luminex
Meso Scale Diagnostics
Others

https://coleofduty.com/market-reports/2020/05/12/array-instruments-market-analyzes-the-impact-followed-by-restraints-and-opportunities-and-projected-developments-2020-2027/

PROTEIN MICROARRAY MARKET 2020 GLOBAL ANALYSIS, OPPORTUNITIES AND FORECAST TO 2026 | BY TOP LEADING VENDORS LIKE AGILENT GENOMICS, ARRAYIT, RAYBIOTECH, BIOTECHNIQUES, THERMO FISHER SCIENTIFIC, APPLIED MICROARRAYS INC, AND MORE?
MAY 12, 2020

Dataintelo offers a latest published report on Global Protein Microarray Market industry analysis and forecast 2019–2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions. The rapidly changing market scenario and initial and future assessment of the impact is covered in the report. The report contains XX pages which highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.

The Major Players Reported in the Market Include:
Agilent Genomics
Arrayit
RayBiotech
BioTechniques
Thermo Fisher Scientific
Applied Microarrays Inc

https://jewishlifenews.com/uncategorized/protein-microarray-market-2020-global-analysis-opportunities-and-forecast-to-2026-by-top-leading-vendors-like-agilent-genomics-arrayit-raybiotech-biotechniques-thermo-fisher-scientific-applied/

Global Microarray Analysis Market Growth 2020: Illumina, Perkinelmer, Merck, GE Healthcare, Arrayit
Microarray Analysis Market Demand 2020
May 7, 2020

The latest study report on the Global Microarray Analysis Market Research 2020-2026 exclusively discusses the upcoming trends alongside an in-depth analysis of the regional landscape of the Microarray Analysis market globally. Furthermore, the worldwide Microarray Analysis market report evaluates the comprehensive details related to demand as well as supply rate, prominent contribution by the leading industry manufacturers, Microarray Analysis market share and growth rate of the Microarray Analysis industry.

Top Players involved in this report are:
Thermo Fisher Scientific
Agilent Technologies
Illumina
Perkinelmer, Inc.
Merck KGaA
GE Healthcare
Molecular Devices (A Subsidiary of Danaher)
Arrayit Corporation
Bio-Rad Laboratories
Microarrays, Inc.

https://www.njmmanews.com/global-microarray-analysis-market-growth-2020-illumina-perkinelmer-merck-ge-healthcare-arrayit/

Work in progress looks like, great find!
“Our lab partner, Arrayit Lab, performs an immunoassay for detection of 2019-Novel Coronavirus (2019-nCoV “COVID-19”) from samples collected by, whole blood by finger stick collection

Maintaining their cutting-edge approach to their health care business...and preparing for the future.

Arrayit website:
Our Services
For Clinics
Electronic Healthcare Records (EHR) interface streamlines confidential transfer of patient information between the reference laboratory and clinic. We also offer clinic-specific requisition forms, kit usage training and daily clinical assistance.
http://www.arrayit.com/SARSCoV2.html

HealthIT.gov website:
What is an electronic health record (EHR)?
An electronic health record (EHR) is a digital version of a patient’s paper chart. EHRs are real-time, patient-centered records that make information available instantly and securely to authorized users. While an EHR does contain the medical and treatment histories of patients, an EHR system is built to go beyond standard clinical data collected in a provider’s office and can be inclusive of a broader view of a patient’s care. EHRs are a vital part of health IT and can:
-Contain a patient’s medical history, diagnoses, medications, treatment plans, immunization dates, allergies, radiology images, and laboratory and test results
-Allow access to evidence-based tools that providers can use to make decisions about a patient’s care
-Automate and streamline provider workflow
One of the key features of an EHR is that health information can be created and managed by authorized providers in a digital format capable of being shared with other providers across more than one health care organization. EHRs are built to share information with other health care providers and organizations – such as laboratories, specialists, medical imaging facilities, pharmacies, emergency facilities, and school and workplace clinics – so they contain information from all clinicians involved in a patient’s care.
https://www.healthit.gov/faq/what-electronic-health-record-ehr

Good digging. Difficult to stay up with the experts.
“ The results presented here suggest that IgE is associated with anti-influenza immunity and their memory responses. Further studies are necessary to elucidate the role of immunoglobulins in influenza infection and to determine possible functional roles of IgE in this disease and its relationship to viral pathophysiology.”

I think so. That’s such a long time ago that I lost track. I don’t ever recall Arrayit officially releasing that info but I believe it was intimated by someone’s DD.

My guess is it is. All the serology tests that I’ve seen have involved only the IgG.

I’ve always seen that they can test both. Just depended on what they were diagnosing.

Ok, they must be working on the site. Some things are changing.

Arrayit SARS-CoV-2 (COVID-19) testing services are available to doctors nationwide.

Haven’t found that quote yet, clue please...

Yes

The pre-symptomatic cancer screening is why I first bought into this company on ‘08.

Complete site UPDATE!

We Also Provide Pre-Symptomatic Ovarian Cancer Screening Services.

Proprietary Technology
accurate results
Knowing your quantitative levels of immunoglobulin E (IgE) against 12 SARS-Cov-2 biomarkers, we ensure a high degree of accuracy and is forward looking for any possible mutations. Knowing the total IgE value allows the doctor to determine how well your body is responding to the virus in antibody production.

I guess not yet...

Re-instated?

Yup, I was glad to see that confirmation.
CLIA certificate number is the same so I would have to believe it’s been renewed but not updated on the CMS site.
Shout out to ScorpGirl for the great find!

From the California Department of Public Health link you provided:

ARRAYIT CORPORATION
License Type CDF
License Description DEEMED STATUS - LICENSED LABORATORY FOR A NON-PHYSICIAN OFFICE LAB (POL) WITH FEDERAL CERTIFICATE OF ACCREDITATION (COA).
Facility License CDF : DEEMED STATUS - LICENSED LABORATORY FOR A NON-PHYSICIAN OFFICE LAB (POL) WITH FEDERAL CERTIFICATE OF ACCREDITATION (COA).
CLIA Number 05D2147467
License ID 349880
Facility Name ARRAYIT CORPORATION
Facility Address 927 THOMPSON PLACE
Facility Address2
Facility City SUNNYVALE
Facility County SANTA CLARA
Facility Zipcode 94085
Facility Zipcode+4
Facility State CA
Telephone Number (408) 744-1331
Fax Number
E-mail ARRAYIT@ARRAYIT.COM
Laboratory Director First Name JULIE
Laboratory Director Middle Name
Laboratory Director Last Name TAGUCHI